Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03369015 · ClinicalTrials.gov registry record · Phase 1
Effect of D-amphetamine on Reward Functioning
A Phase 1 study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 1
- Development phase
- 68
- Enrollment target
NCT03369015 is a Phase 1 study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 68 participants.
The verdict
NCT03369015, a Phase 1 study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 68 participants
- Enrollment target
Study Summary
The purpose of this study is to establish the dose-response curve for therapeutic doses of d-amphetamine on tasks of motivation and reward learning in the same participants and to use d-amphetamine as a dopaminergic probe to test newer theories about the role of dopamine in reward-related decision-making.
Interventions
- DRUG Placebo
- DRUG 10 mg d-amphetamine
- DRUG 20mg d-amphetamine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2018-01-24 |
| Est. Completion | 2019-05-23 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03369015
The ClinicalTrials.gov registry entry for NCT03369015 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT03369015 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03369015 about?
NCT03369015 is a clinical study titled "Effect of D-amphetamine on Reward Functioning". The purpose of this study is to establish the dose-response curve for therapeutic doses of d-amphetamine on tasks of motivation and reward learning in the same participants and to use d-amphetamine as a dopaminergic probe to test newer theories about the role of dopamine in reward-related decision-m...
What is the current status of trial NCT03369015?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 68 participants. The study started on 2018-01-24. Estimated completion is 2019-05-23.
What interventions are being tested in trial NCT03369015?
The interventions under investigation include: Placebo (DRUG), 10 mg d-amphetamine (DRUG), 20mg d-amphetamine (DRUG).
Who is sponsoring clinical trial NCT03369015?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.